Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Orchard Therapeutics Announces $150M Series C Financing To Advance Gene Therapy Pipeline
Venture Capital

Orchard Therapeutics Announces $150M Series C Financing To Advance Gene Therapy Pipeline

by vcaonline.com posted 1year ago 73 views
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy PipelineProceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform BOSTON and LONDON, August 13, 2018-- Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the completion of an oversubscribed $150 million Series C financing.

In this article